Enanta Pharmaceuticals Inc (ENTA)

[willyw]

This makes sense to me, particularly since;

1) ENTA now has BOTH regular milestones, but also royalties. (we may get some color on the G-4 program, EU expansion, VA, Canada)

2) ENTA has pre-clinical drug candidates which they are developing themselves in house. (would be great to get an update)

Of course, I am hoping the CC will be an opportunity to talk about income or asset development. Any new assets?

I don't expect they can talk much about the joint ENTA/ABBVIE 2nd gen compounds other than what Abbvie has already mentioned; AASLD release.